Overview of a framework for prioritizing variants of uncertain significance (VUS) identified by comprehensive genomic profiling (CGP) (IMAGE)
Caption
Overview of a framework for prioritizing variants of uncertain significance (VUS) identified by comprehensive genomic profiling (CGP), based on real-world data from 2,172 tests showing a higher prevalence of VUS than pathogenic variants in BRCA1/2. (Nakahara et al. European Journal of Human Genetics. March 3, 2026)
Credit
Nakahara et al. European Journal of Human Genetics. March 3, 2026
Usage Restrictions
News organizations may use or redistribute this image, with proper attribution, as part of news coverage related to this press release only.
License
Licensed content